Filing Details

Accession Number:
0000820081-13-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-08 10:29:30
Reporting Period:
2013-05-07
Filing Date:
2013-05-08
Accepted Time:
2013-05-08 10:29:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820081 Cambrex Corp CBM Pharmaceutical Preparations (2834) 222476135
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227835 Gregory Sargen One Meadowlands Plaza
East Rutherford NJ 07073
Executive Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-07 2,500 $7.39 35,819 No 4 M Direct
Common Stock Disposition 2012-05-07 2,500 $12.42 33,319 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-07 2,500 $0.00 2,500 $7.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-07-27 No 4 M Direct
Footnotes
  1. Exercisable in one-quarter increments on the anniversary date of the grant over four years.